Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Douglas Teixeira Leffa, MD, PhD

Douglas Teixeira Leffa, MD, PhD

Dr Leffa is a psychiatry resident at the University of Pittsburgh Medical Center.

Articles by Douglas Teixeira Leffa, MD, PhD

Psychiatric Times with heart

What We Love About Psychiatry: Reflections From the Field

ByJohn J. Miller, MD,Allison S. Baker, MD,Douglas Teixeira Leffa, MD, PhD,Timothy Wilens, MD,Benjamin E. Yerys, PhD,Jennie Byrne, MD, PhD,Elysia Davis, PhD,Benjamin Hankin, PhD,Gary W. Small, MD

February 14th 2026

Adult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis

ByDouglas Teixeira Leffa, MD, PhD,Heidi Anne Duerr, MPH

January 22nd 2026

Douglas Leffa, MD, PhD, shares highlights from a poster at the APSARD conference examining severity and age of diagnosis.

Latest Updated Articles

Trending on Psychiatric Times

September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News

Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression

VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027

The Psychiatric Pipeline in Review: Quarter 3, 2026

Nature vs Nurture: The Interplay Between Genetics and Environmental Influences